Source:http://linkedlifedata.com/resource/pubmed/id/16225643
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2005-10-17
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0007-0963
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
153
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1086-8
|
pubmed:meshHeading |
pubmed-meshheading:16225643-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:16225643-Camptothecin,
pubmed-meshheading:16225643-Female,
pubmed-meshheading:16225643-Humans,
pubmed-meshheading:16225643-Male,
pubmed-meshheading:16225643-Middle Aged,
pubmed-meshheading:16225643-Mycosis Fungoides,
pubmed-meshheading:16225643-Skin Neoplasms
|
pubmed:year |
2005
|
pubmed:articleTitle |
Irinotecan (CPT-11) in the treatment of mycosis fungoides.
|
pubmed:publicationType |
Letter,
Case Reports
|